Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2017

01-11-2017 | Editorial

Eliminating Duodenoscope-Associated Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE): In Search of an Optimal Strategy

Authors: Divyanshoo R. Kohli, Thomas E. Grys, Rahul Pannala

Published in: Digestive Diseases and Sciences | Issue 11/2017

Login to get access

Excerpt

A much feared and increasingly commonplace complication of gastrointestinal endoscopic procedures is endoscope-to-patient transmission of bacterial pathogens resistant to multiple antibiotics, known as multi-drug-resistant organisms (MDRO). Multiple outbreaks of duodenoscope-associated infections with MDRO, including carbapenem-resistant Enterobacteriaceae (CRE), have been reported in the USA and in Europe [1, 2]. The presence of an elevator mechanism in duodenoscopes used in endoscopic retrograde cholangiopancreatography (ERCP) impedes effective decontamination and has been implicated in the risk of persistent bacterial contamination [3]. Several strategies have been proposed to mitigate the risk of transmission, including strict adherence to manufacturer-recommended high-level disinfection (HLD), universal ethylene oxide (EtO) sterilization, the culturing and sequestering of endoscopes, and patient screening with polymerase chain reaction (PCR)-based tests. Nevertheless, there is substantial variability in the strategies being utilized across institutions, and outcomes data for these approaches are limited. …
Literature
1.
go back to reference Wendorf KA, Kay M, Baliga C, et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol. 2015;36:634–642.CrossRefPubMed Wendorf KA, Kay M, Baliga C, et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol. 2015;36:634–642.CrossRefPubMed
2.
go back to reference O’Horo JC, Farrell A, Sohail MR, Safdar N. Carbapenem-resistant enterobacteriaceae and endoscopy: an evolving threat. Am J Infect Control. 2016;44:1032–1036.CrossRefPubMedPubMedCentral O’Horo JC, Farrell A, Sohail MR, Safdar N. Carbapenem-resistant enterobacteriaceae and endoscopy: an evolving threat. Am J Infect Control. 2016;44:1032–1036.CrossRefPubMedPubMedCentral
4.
go back to reference Smith ZL, Dua A, Saeian K, Ledeboer NA, Graham MB, Aburajab M, et al. A novel protocol obviates endoscope sampling for carbapenem-resistant enterobacteriaceae: experience of a center with a prior outbreak. Dig Dis Sci. (Epub ahead of print). doi: 10.1007/s10620-017-4669-9. Smith ZL, Dua A, Saeian K, Ledeboer NA, Graham MB, Aburajab M, et al. A novel protocol obviates endoscope sampling for carbapenem-resistant enterobacteriaceae: experience of a center with a prior outbreak. Dig Dis Sci. (Epub ahead of print). doi: 10.​1007/​s10620-017-4669-9.
9.
go back to reference Reprocessing Guideline Task Force, Petersen BT, Cohen J, et al. Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update. Gastrointest Endosc. 2017;85:282–294.CrossRef Reprocessing Guideline Task Force, Petersen BT, Cohen J, et al. Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update. Gastrointest Endosc. 2017;85:282–294.CrossRef
11.
go back to reference Ma GK, Pegues DA, Kochman ML, et al. Implementation of a systematic culturing program to monitor the efficacy of endoscope reprocessing: outcomes and costs. Gastrointest Endosc. 2017. doi:10.1016/j.gie.2017.05.001. Ma GK, Pegues DA, Kochman ML, et al. Implementation of a systematic culturing program to monitor the efficacy of endoscope reprocessing: outcomes and costs. Gastrointest Endosc. 2017. doi:10.​1016/​j.​gie.​2017.​05.​001.
12.
go back to reference Gazdik MA, Coombs J, Burke JP, Lopansri BK. Comparison of two culture methods for use in assessing microbial contamination of duodenoscopes. J Clin Microbiol. 2016;54:312–316.CrossRefPubMedPubMedCentral Gazdik MA, Coombs J, Burke JP, Lopansri BK. Comparison of two culture methods for use in assessing microbial contamination of duodenoscopes. J Clin Microbiol. 2016;54:312–316.CrossRefPubMedPubMedCentral
13.
go back to reference Ross AS, Baliga C, Verma P, Duchin J, Gluck M. A quarantine process for the resolution of duodenoscope-associated transmission of multidrug-resistant Escherichia coli. Gastrointest Endosc. 2015;82:477–483.CrossRefPubMed Ross AS, Baliga C, Verma P, Duchin J, Gluck M. A quarantine process for the resolution of duodenoscope-associated transmission of multidrug-resistant Escherichia coli. Gastrointest Endosc. 2015;82:477–483.CrossRefPubMed
14.
go back to reference Rutala WA, Weber DJ. Outbreaks of carbapenem-resistant enterobacteriaceae infections associated with duodenoscopes: what can we do to prevent infections? Am J Infect Control. 2016;44:e47–e51.CrossRefPubMed Rutala WA, Weber DJ. Outbreaks of carbapenem-resistant enterobacteriaceae infections associated with duodenoscopes: what can we do to prevent infections? Am J Infect Control. 2016;44:e47–e51.CrossRefPubMed
15.
go back to reference Almario CV, May FP, Shaheen NJ, et al. Cost utility of competing strategies to prevent endoscopic transmission of carbapenem-resistant enterobacteriaceae. Am J Gastroenterol. 2015;110:1666–1674.CrossRefPubMedPubMedCentral Almario CV, May FP, Shaheen NJ, et al. Cost utility of competing strategies to prevent endoscopic transmission of carbapenem-resistant enterobacteriaceae. Am J Gastroenterol. 2015;110:1666–1674.CrossRefPubMedPubMedCentral
16.
go back to reference Kim S, Russell D, Mohamadnejad M, et al. Risk factors associated with the transmission of carbapenem-resistant enterobacteriaceae via contaminated duodenoscopes. Gastrointest Endosc. 2016;83:1121–1129.CrossRefPubMed Kim S, Russell D, Mohamadnejad M, et al. Risk factors associated with the transmission of carbapenem-resistant enterobacteriaceae via contaminated duodenoscopes. Gastrointest Endosc. 2016;83:1121–1129.CrossRefPubMed
Metadata
Title
Eliminating Duodenoscope-Associated Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE): In Search of an Optimal Strategy
Authors
Divyanshoo R. Kohli
Thomas E. Grys
Rahul Pannala
Publication date
01-11-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4761-1

Other articles of this Issue 11/2017

Digestive Diseases and Sciences 11/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.